Mitochondrially-targeted therapeutics

Mitochondrially-targeted therapeutics has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Mar 14, 2025: “Telomere length in offspring is determined by mitochondrial-nuclear communication at fertilization”.

Intervention

1 paper studies it1 findingUpdated

See all 1 papers on mitochondrially-targeted therapeutics

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Channel 7 Children’s Research Foundation and 1 more
  • 1 of 1 finding with company ties
  • Animals1

What did studies of mitochondrially-targeted therapeutics find?

1

Studies of mitochondrially-targeted therapeutics measured one outcome, neonatal telomere length.

Neonatal telomere length

upin mice1

1 study
  1. Mitochondrially-targeted therapeutics increase neonatal telomere length in mice (preimplantation telomere resetting).

    Animalspreimplantation telomere resetting

More on Neonatal telomere length

Latest